Today we have Dr Brian Kennedy, who has recently come onboard as President and CEO of the Buck Institute. Dr Kennedy brought his lab with him from the University of Washington in Seattle. Their work focuses on aging genes in model organisms and Dr Kennedy is particularly interested in how this translates into aging in humans, as well as looking at a group of rare but informative premature aging diseases.

The Greenberg lab works on the molecular mechanisms of stroke. Dr Greenberg is particularly interested in the role of neurogenesis in tissue repair following stroke, and in this podcast he discusses how neurogenesis may be manipulated in order to improve recovery following stroke, as well as some new directions for the lab.

The Lithgow Lab  focuses on mechanisms of lifespan extension and survival in the model organism, the nematode worm,  with a particular  emphasis on stress response. Dr Lithgow has initiated collaborations with other labs at the Buck in order to study various aspects of stress – including the effects of genetic and pharmacological manipulation on stress resistance – and how this pertains to lifespan and age-related disease.